Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

CLSN:US

2.6700 USD 0.0100 0.37%

As of 20:10:00 ET on 03/31/2015.

Snapshot for Celsion Corp (CLSN)

Open: 2.6400 Day's Range: 2.5900 - 2.6700 Volume: 43,075
Previous Close: 2.6800 52wk Range: 2.1500 - 3.7300 1-Yr Rtn: -23.05%

Stock Chart for CLSN

No chart data available.
  • CLSN:US 2.6700
  • 1D
  • 1M
  • 1Y
2.6800
Interactive CLSN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CLSN

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.3418
Est. EPS (USD) (12/2015) -1.3600
Est. PEG Ratio -
Market Cap (M USD) 53.36
Shares Outstanding (M) 19.98
30 Day Average Volume 350,184
Price/Book (mrq) 1.3705
Price/Sale (ttm) 97.9080
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/08/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CLSN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CLSN

Celsion Corporation is a development company specializing in heat based treatments for cancer and other diseases. The Company's products include a heat activated liposomal form of doxorubicin for the treatment for liver and breast cancers.

Michael H TardugnoChairman/President/CEOKhursheed AnwerExec VP/Chief Scientific Ofcr
Jeffrey W Church "Jeff"Senior VP/CFO/SecretaryNicholas BorysVP/Chief Medical Officer
More Company Profile & Key Executives for CLSN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil